Can integrated multi-testing strengthen TB care and help detect more in one visit?
The World Health Organization (WHO) has emphasized the potential of integrated multi-testing platforms to enhance tuberculosis (TB) care by allowing simultaneous detection of TB, HIV, and viral hepatitis. However, experts highlight that the effectiveness of such platforms depends on using the appropriate clinical samples for each disease, as TB typically requires respiratory samples while other infections need blood or cervical samples. As WHO develops guidelines for multiplex testing by September 2025, the focus will be on establishing principles for integrated testing that accommodates these distinctions.